Alpha Invitro Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 139.07%
- Profit Growth 279.40%
- Ebitda 805.73%
- Net Worth 155.81%
- Total Assets 153.70%
About Alpha Invitro Diagnostics
Alpha Invitro Diagnostics Private Limited (AIDPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 November 2020 (Four years and two months 21 days old ). Its registered office is in Varanasi, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Pawan Sharma and Sanjay Kumar serve as directors at the Company.
Company Details
-
Location
Varanasi, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85190UP2020PTC137855
-
Company No.
137855
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Nov 2020
-
Date of AGM
05 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Alpha Invitro Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawan Sharma
|
Director | 30-Jun-2022 | Current |
|
Sanjay Kumar
|
Director | 18-Apr-2023 | Current |
Financial Performance of Alpha Invitro Diagnostics.
Alpha Invitro Diagnostics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 139.07% increase. The company also saw a substantial improvement in profitability, with a 279.4% increase in profit. The company's net worth Soared by an impressive increase of 155.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alpha Invitro Diagnostics?
Unlock access to Alpha Invitro Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Ldpl Diagnostics Private LimitedPawan Sharma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Alpha Invitro Diagnostics?
Alpha Invitro Diagnostics has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alpha Invitro Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alpha Invitro Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
